SONON 300C Wireless Portable Ultrasound

About Healcerion Co., Ltd.

Company Overview and Commitment to Innovation

Established in 2012, Healcerion Co., Ltd. has revolutionized the field of medical diagnostics with the creation of the world’s first wire-free ultrasound, Sonon. Driven by the belief that ultrasound diagnostic devices should be portable and accessible, Healcerion has been at the forefront of reforming medical techniques that have remained unchanged for the past 70 years.

Key Milestones and Achievements

• 2012: Healcerion was founded and quickly gained recognition, earning a venture business certification and winning the Superstar V “Top-Ranked” Award at the National Entrepreneurship Competition.
• 2014: Launched the portable wireless ultrasound diagnostic device (Sonon 300C) and achieved several significant milestones, including a Gold Award at the iENA Nuremburg exhibition in Germany and KFDA/GMP certification.
• 2016: Introduced the Sonon 300L, a linear type wireless ultrasound diagnostic device, and expanded its global footprint by acquiring Canada product certification and forming overseas business cooperations.
• 2018: Designated as a global small-sized strong company and received numerous accolades, including the WHO innovative medical device recognition and the Minister of Health and Welfare Award.
• 2020: Adapted to the global pandemic by securing Russian COVID-19 procurement orders and being selected as a World Bank COVID-19 procurement item.

Innovative Product Line: SONON Series

Healcerion's flagship product, the SONON series, is renowned for its portability and wireless capabilities, making it the world's most freely portable ultrasound. The SONON devices are designed to go wherever they are needed, providing faster and better diagnostic capabilities directly at the patient's location. Key features of the SONON series include:

• Wireless Connectivity: Eliminates the need for cumbersome wires, allowing for greater mobility and ease of use.
• High-Quality Imaging: Provides clear and accurate ultrasound images to aid in diagnosis.
• User-Friendly Interface: Designed for ease of use, making it accessible for various medical professionals.

Vision and Future Aspirations

Healcerion aims to continue leading the innovation in portable ultrasound technology, driven by a vision of making advanced medical diagnostics more accessible and efficient. The establishment of the Artificial Intelligence & Platform Research Institute (AGI) in 2020 underscores the company's commitment to integrating cutting-edge technology and AI into their medical devices.

Global Reach and Recognitions

Healcerion has garnered numerous certifications and recognitions that attest to its commitment to quality and innovation:

• FDA Certifications: Multiple products, including the Sonon 300C and Sonon 300L, have received FDA certification.
• CE Medical Device Certification: Ensuring compliance with European standards.
• Global Awards: Including the Red Herring Global top 100, the IR52 Jang Young-sil Award, and various commendations from government and international bodies.